Pharma Pulse 3/25/25: The Unfinished Work of Healthcare Reform, Preventing Adverse Drug Events & more

PAP 2025: The Unfinished Work of Healthcare Reform

Jonathan James, CEO, Hope Charities, discusses how, despite policy advancements, millions of people still face barriers to healthcare access.

Preventing Adverse Drug Events: A Call to Action for Pharmacists

National Adverse Drug Event Awareness Day was established to promote awareness, drive policy changes, and encourage health care professionals and patients to prioritize medication safety.

AI-Powered Databases Boost the Alzheimer’s Drug Discovery Process

Researchers studying Alzheimer’s disease are using artificial intelligence-powered databases to accelerate the drug discovery process by making it easier to sift through vast amounts of biomedical data.

Dr. Mike Graham Appointed as New Head of R&D for Bayer’s Crop Science Division

Bayer announced that Dr. Mike Graham will become the new Head of Research & Development for Bayer’s Crop Science division and serve as member of the Leadership Team. He will succeed Dr. Robert Reiter who has decided to retire after 27 years with the company and 34 years in the industry. In his current role, Graham is leading the company’s Plant Breeding organization and has profound expertise in R&D and agriculture. The change will become effective as of April 15, 2025.

Steve Chriscoe on LinkedIn

It was a lot of fun to do this with Pharmaceutical Executive! Check out our roundtable discussions on #CAR-T research

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs